Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Edan

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Presse Medicale (Paris, France : 1983)|March 19, 2004
[Aggressive multiple sclerosis. Definition and specific therapeutic indication]Gilles Edan
Journal of the Neurological Sciences|October 19, 2010
A new treatment era in multiple sclerosis: clinical applications of new conceptsGilles Edan, Emmanuelle Leray
Journal of the Neurological Sciences|May 9, 2006
Assessment of cognitive dysfunction in multiple sclerosisEric Sartori, Gilles Edan
La Revue Du Praticien|September 5, 2006
[Drug therapy in multiple sclerosis]Emmanuelle Le Page, Gilles Edan
Journal of the Neurological Sciences|February 10, 2009
Long-term experience with induction treatment regimens in multiple sclerosisEmmanuelle Le Page, Gilles Edan
Drugs|September 19, 2023
Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?Gilles Edan, Emmanuelle Le Page
CNS Drugs|May 10, 2013
Induction therapy for patients with multiple sclerosis: why? When? How?Gilles Edan, Emmanuelle Le Page
Medical Image Analysis|July 5, 2016
Imaging biomarkers in multiple Sclerosis: From image analysis to population imagingChristian Barillot, Gilles Edan, Olivier Commowick
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2017
An excessive risk of suicide may no longer be a reality for multiple sclerosis patientsShoshannah Kalson-Ray, Gilles Edan, Emmanuelle Leray, et al.
Journal of the Neurological Sciences|July 21, 2004
Rationale for the use of mitoxantrone in multiple sclerosisGilles Edan, Sean Morrissey, Emmanuelle Le Page
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Presse Medicale (Paris, France : 1983)|March 19, 2004
[Aggressive multiple sclerosis. Definition and specific therapeutic indication]Gilles Edan
Journal of the Neurological Sciences|October 19, 2010
A new treatment era in multiple sclerosis: clinical applications of new conceptsGilles Edan, Emmanuelle Leray
Journal of the Neurological Sciences|May 9, 2006
Assessment of cognitive dysfunction in multiple sclerosisEric Sartori, Gilles Edan
La Revue Du Praticien|September 5, 2006
[Drug therapy in multiple sclerosis]Emmanuelle Le Page, Gilles Edan
Journal of the Neurological Sciences|February 10, 2009
Long-term experience with induction treatment regimens in multiple sclerosisEmmanuelle Le Page, Gilles Edan
Drugs|September 19, 2023
Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?Gilles Edan, Emmanuelle Le Page
CNS Drugs|May 10, 2013
Induction therapy for patients with multiple sclerosis: why? When? How?Gilles Edan, Emmanuelle Le Page
Medical Image Analysis|July 5, 2016
Imaging biomarkers in multiple Sclerosis: From image analysis to population imagingChristian Barillot, Gilles Edan, Olivier Commowick
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2017
An excessive risk of suicide may no longer be a reality for multiple sclerosis patientsShoshannah Kalson-Ray, Gilles Edan, Emmanuelle Leray, et al.
Journal of the Neurological Sciences|July 21, 2004
Rationale for the use of mitoxantrone in multiple sclerosisGilles Edan, Sean Morrissey, Emmanuelle Le Page
Pageof 15